These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2938250)

  • 41. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term clinical follow-up studies of basic therapy in rheumatoid arthritis].
    Piaĭ LT
    Ter Arkh; 1981; 53(7):67-9. PubMed ID: 7292319
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sulfhydryl maintenance treatment in rheumatoid polyarthritis. A series of 120 cases followed for 10 years and a study of possibilities of changing the drug].
    Camus JP; Koeger AC; Struz P; Laveant C
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):31-3. PubMed ID: 3704509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine.
    Nuotio P; Nissilä M; Ilonen J
    Scand J Rheumatol; 1986; 15(3):255-8. PubMed ID: 3492038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-penicillamine-induced acute hypersensitivity pneumonitis and cholestatic hepatitis in a patient with rheumatoid arthritis.
    Kumar A; Bhat A; Gupta DK; Goel A; Malaviya AN
    Clin Exp Rheumatol; 1985; 3(4):337-9. PubMed ID: 4085166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.
    Mowat AG
    Ann Rheum Dis; 1978 Feb; 37(1):1-8. PubMed ID: 629595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membranous glomerulonephritis in patients with rheumatoid arthritis.
    Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T
    Clin Ther; 1994; 16(6):1000-6. PubMed ID: 7697679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
    De La Mata J; Blanco FJ; Gómez-Reino JJ
    Ann Rheum Dis; 1995 Nov; 54(11):881-5. PubMed ID: 7492236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of D-penicillamine with gold salts: in vivo studies on gold chelation and in vitro studies on protein binding.
    Davis P; Barraclough D
    Arthritis Rheum; 1977; 20(7):1413-8. PubMed ID: 911360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug.
    Hirohata S; Lipsky PE
    Clin Immunol Immunopathol; 1993 Jan; 66(1):43-51. PubMed ID: 8440072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
    Yamauchi H; Hayashi M; Kasamatsu S; Suda H; Nakata K; Sasano M; Iso T
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):275-82. PubMed ID: 2408978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.